Development of focal adhesion kinase inhibitors in cancer therapy.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Anti-Cancer Agents in Medicinal Chemistry

• Publication date

  2011-08-31

• Fields of study

  Medicine

• Identifiers
  DOI 10.2174/187152011796817628PMID 21787276
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibition of focal adhesion kinase as a potential therapeutic strategy for imatinib-resistant gastrointestinal stromal tumor

  2009cited by this paper
• A novel small molecule inhibitor of FAK decreases growth of human pancreatic cancer

  2009cited by this paper
• Focal adhesion kinase as potential target for cancer therapy (Review).

  2009cited by this paper
• Small molecule chloropyramine hydrochloride (C4) targets the binding site of focal adhesion kinase and vascular endothelial growth factor receptor 3 and suppresses breast cancer growth in vivo.

  2009cited by this paper
• Novel Agents on the Horizon for Cancer Therapy

  2009cited by this paper
• The Pyk2 FERM domain as a target to inhibit glioma migration

  2009cited by this paper
• Focal Adhesion Kinase Versus p53: Apoptosis or Survival?

  2008cited by this paper
• TAE226, a dual inhibitor for FAK and IGF-IR, has inhibitory effects on mTOR signaling in esophageal cancer cells.

  2008cited by this paper
• A small molecule inhibitor, 1,2,4,5-benzenetetraamine tetrahydrochloride, targeting the y397 site of focal adhesion kinase decreases tumor growth.

  2008cited by this paper
• Focal Adhesion Kinase: Targeting Adhesion Signaling Pathways for Therapeutic Intervention

  2008cited by this paper
• Crystal Structures of the FAK Kinase in Complex with TAE226 and Related Bis-Anilino Pyrimidine Inhibitors Reveal a Helical DFG Conformation

  2008cited by this paper
• Nuclear FAK promotes cell proliferation and survival through FERM-enhanced p53 degradation.

  2008cited by this paper
• Antitumor activity and pharmacology of a selective focal adhesion kinase inhibitor, PF-562,271.

  2008cited by this paper
• A novel low‐molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth

  2007cited by this paper
• Therapeutic efficacy of a novel focal adhesion kinase inhibitor TAE226 in ovarian carcinoma.

  2007cited by this paper
• Inhibition of both focal adhesion kinase and insulin-like growth factor-I receptor kinase suppresses glioma proliferation in vitro and in vivo

  2007cited by this paper
• Vascular endothelial growth factor receptor-3 and focal adhesion kinase bind and suppress apoptosis in breast cancer cells.

  2006cited by this paper
• Antisense oligonucleodes targeting the focal adhesion kinase inhibit proliferation, induce apoptosis and cooperate with cytotoxic drugs in human glioma cells

  2006cited by this paper
• Focal Adhesion Kinase Targeting Using In vivo Short Interfering RNA Delivery in Neutral Liposomes for Ovarian Carcinoma Therapy

  2006cited by this paper
• Effect of focal adhesion kinase (FAK) downregulation with FAK antisense oligonucleotides and 5-fluorouracil on the viability of melanoma cell lines

  2005cited by this paper
• The role of focal-adhesion kinase in cancer — a new therapeutic opportunity

  2005cited by this paper
• Focal Adhesion Kinase Silencing Augments Docetaxel-Mediated Apoptosis in Ovarian Cancer Cells

  2005cited by this paper
• Role of lymphangiogenic factors in tumor metastasis.

  2004cited by this paper
• Vascular endothelial growth factor C and vascular endothelial growth factor receptor 2 are related closely to the prognosis of patients with ovarian carcinoma

  2004cited by this paper
• Expression and significance of VEGF-C and FLT-4 in gastric cancer.

  2004cited by this paper
• Differential role of proline-rich tyrosine kinase 2 and focal adhesion kinase in determining glioblastoma migration and proliferation.

  2003cited by this paper
• Dual Inhibition of Focal Adhesion Kinase and Epidermal Growth Factor Receptor Pathways Cooperatively Induces Death Receptor-mediated Apoptosis in Human Breast Cancer Cells*

  2002cited by this paper
• The association of ASAP1, an ADP ribosylation factor-GTPase activating protein, with focal adhesion kinase contributes to the process of focal adhesion assembly.

  2002cited by this paper
• Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis

  2001cited by this paper
• VEGF-D promotes the metastatic spread of tumor cells via the lymphatics

  2001cited by this paper
• The Focal Adhesion Kinase Suppresses Transformation-associated, Anchorage-independent Apoptosis in Human Breast Cancer Cells

  2000cited by this paper
• The COOH-terminal domain of the focal adhesion kinase induces loss of adhesion and cell death in human tumor cells.

  1998cited by this paper
• Characterization of Graf, the GTPase-activating Protein for Rho Associated with Focal Adhesion Kinase

  1998cited by this paper
• Signaling through focal adhesion kinase

  1997cited by this paper
• Induction of Apoptosis after Expression of PYK2, a Tyrosine Kinase Structurally Related to Focal Adhesion Kinase

  1997cited by this paper
• p130Cas, a Substrate Associated with v-Src and v-Crk, Localizes to Focal Adhesions and Binds to Focal Adhesion Kinase*

  1996cited by this paper
• Autophosphorylation of the focal adhesion kinase, pp125FAK, directs SH2-dependent binding of pp60src

  1994cited by this paper
• Direct interaction of v-Src with the focal adhesion kinase mediated by the Src SH2 domain.

  1994cited by this paper
• Focal adhesion kinase: structure and signalling

  1994cited by this paper
• Stable association of pp60src and pp59fyn with the focal adhesion-associated protein tyrosine kinase, pp125FAK

  1994cited by this paper
• Expression of focal adhesion kinase gene and invasive cancer.

  1993cited by this paper

• Methotrexate-Conjugated Therapeutic Carbon Dots with Intrinsic Anticancer Activity for Breast Cancer Cell Inhibition

  2025cites this paper
• Targeting Focal Adhesion Kinase in Lung Diseases: Current Progress and Future Directions

  2025cites this paper
• Combining QSAR techniques, molecular docking, and molecular dynamics simulations to explore anti-tumor inhibitors targeting Focal Adhesion Kinase

  2024cites this paper
• Chenodeoxycholic acid inhibits lung adenocarcinoma progression via the integrin α5β1/FAK/p53 signaling pathway.

  2022cites this paper
• Phosphohistidine signaling promotes FAK-RB1 interaction and growth factor-independent proliferation of esophageal squamous cell carcinoma

  2022cites this paper
• The Development of FAK Inhibitors: A Five-Year Update

  2022influential citation
• Purine adducts as a presumable missing link for aristolochic acid nephropathy‐related cellular energy crisis, potential anti‐fibrotic prevention and treatment

  2021cites this paper
• Elucidating the role of the kinase activity of endothelial cell focal adhesion kinase in angiocrine signalling and tumour growth

  2021cites this paper
• CDCA attenuates LUAD pathogenesis progression via integrin α5β1/FAK/p53 signalling pathway

  2021cites this paper
• FAK inhibitors as promising anticancer targets: present and future directions.

  2021cites this paper
• Focal adhesion kinase—An emerging viable target in cancer and development of focal adhesion kinase inhibitors

  2020cites this paper
• Exposure time versus cytotoxicity for anticancer agents

  2019cites this paper
• INVESTIGATING THE MOLECULAR REGULATION OF ANGIOGENESIS IN THE HEART

  2019cites this paper
• The roles of nuclear focal adhesion kinase (FAK) on Cancer: a focused review

  2019cites this paper
• Glucose Drives Growth Factor–Independent Esophageal Cancer Proliferation via Phosphohistidine–Focal Adhesion Kinase Signaling

  2019cites this paper
• FAK inhibitors in Cancer, a patent review

  2018cites this paper
• Preparation, in vitro and in vivo evaluation, and molecular dynamics (MD) simulation studies of novel F-18 labeled tumor imaging agents targeting focal adhesion kinase (FAK)

  2018cites this paper
• Focal Adhesion- and IGF1R-Dependent Survival and Migratory Pathways Mediate Tumor Resistance to mTORC1/2 Inhibition.

  2017cites this paper
• Synthesis and evaluation of novel F-18-labeled pyrimidine derivatives: potential FAK inhibitors and PET imaging agents for cancer detection

  2017cites this paper
• Synthesis, biological evaluation, and molecular dynamics (MD) simulation studies of three novel F-18 labeled and focal adhesion kinase (FAK) targeted 5-bromo pyrimidines as radiotracers for tumor.

  2017cites this paper
• The effects of CEP-37440, an inhibitor of focal adhesion kinase, in vitro and in vivo on inflammatory breast cancer cells

  2016cites this paper
• Restoration of TRAIL-induced apoptosis in resistant human pancreatic cancer cells by a novel FAK inhibitor, PH11.

  2015cites this paper
• Design and evaluation of a real-time activity probe for focal adhesion kinase.

  2015cites this paper
• Design, synthesis, and evaluation of novel imidazo[1,2-a][1,3,5]triazines and their derivatives as focal adhesion kinase inhibitors with antitumor activity.

  2015cites this paper
• Dissecting fibrosis: therapeutic insights from the small-molecule toolbox

  2015cites this paper
• SRChing for the substrates of Src

  2014cites this paper
• Inhibition of both focal adhesion kinase and fibroblast growth factor receptor 2 pathways induces anti-tumor and anti-angiogenic activities.

  2014cites this paper
• The role of FAK in tumor metabolism and therapy.

  2014influential citation
• Design of novel focal adhesion kinase inhibitors using 3D-QSAR and molecular docking

  2014cites this paper
• Crosstalk between kinases, phosphatases and miRNAs in cancer.

  2014cites this paper
• Focal adhesion kinase is a regulator of F-actin dynamics

  2013cites this paper
• Overexpression of focal adhesion kinase correlates with increased lymph node metastasis and poor prognosis in non-small-cell lung cancer

  2013cites this paper
• Down-regulation of focal adhesion signaling in response to cyclophilin A knockdown in human endometrial cancer cells, implicated by cDNA microarray analysis.

  2013cites this paper
• Novel insights into the biology of interleukin-32

  2013cites this paper
• Focal adhesion kinase is a phospho-regulated repressor of Rac and proliferation in human endothelial cells

  2012cites this paper